Nervous system diseases and disorders are highly prevalent and substantially contribute to the overall disease burden. Despite significant information provided

Compared with other disease areas, central nervous system (CNS) disorders have had the highest failure rate for new compounds in advanced clinical trials. Most

Improving and Accelerating Therapeutic Development for Nervous System Disorders is the summary of a workshop convened by the IOM Forum on Neuroscience and Nervo

Prominent experimentalists critically review the animal models widely used in developing powerful new therapies for central nervous system diseases. Coverage in